Hormone Therapy for Lung Cancer Merrick NY

Taking a combination form of hormone replacement therapy, which includes both estrogen and progestin, increases a woman's risk for dying from lung cancer, a new study has found. The finding stems from an analysis of data from the Women's Health Initiative trial on 16,608 postmenopausal women, aged 50 to 79, in the United States who had been randomly assigned to take either a once-daily tablet of 0.625 milligrams conjugated equine estrogen plus 2.5 mg medroxyprogesterone acetate or a placebo.

Local Companies

North Shore Univ Hospital
516-496-6400
221 Jericho Turnpike
Syosset, NY
Mary Immaculate Hospital
718-558-6900
88-25 153rd Street
Jamaica, NY
North Shore Univ Hospital
516-719-3000
888 Old Country Road
Plainview, NY
Jamaica Hospital Med Center
718-206-6000
8900 Van Wyck Expressway
Jamaica, NY
Long Beach Medical Center
516-897-1000
455 East Bay Drive
Long Beach, NY
Dry Harbor Nursing & Rehab Center
(718) 565-4200
61-35 Dry Harbor Rd
Middle Village, NY
Glen Cove Hospital
516-674-7300
101 St Andrews Lane
Glen Cove, NY
Flushing Hospital Medical Ctr
718-670-5000
45th Ave At Parsons Boulevard
Flushing, NY
Bronx Children'S Psych Center
718-239-3600
1000 Waters Place
Bronx, NY
Interfaith Medical Center
718-613-4000
1545 Atlantic Avenue
Brooklyn, NY
Data Provided by:
    

Provided By:

SATURDAY, Sept. 19 (HealthDay News) -- Taking a combination form of hormone replacement therapy, which includes both estrogen and progestin, increases a woman's risk for dying from lung cancer, a new study has found.

The finding stems from an analysis of data from the Women's Health Initiative trial on 16,608 postmenopausal women, aged 50 to 79, in the United States who had been randomly assigned to take either a once-daily tablet of 0.625 milligrams conjugated equine estrogen plus 2.5 mg medroxyprogesterone acetate or a placebo.

After eight years, 73 women taking the hormone therapy and 40 women in the placebo group had died of lung cancer. That meant, according to the researchers, that women who took the drug were 71 percent more likely to die from the disease.

The study also found that women taking the hormone therapy were 28 percent more likely to be diagnosed with lung cancer, although the study noted that the finding was not statistically significant.

"Treatment with estrogen plus progestin in postmenopausal women ... increased the number of deaths from lung cancer, in particular deaths from non-small-cell lung cancer," concluded Rowan Chlebowski, of the Los Angeles Biomedical Research Institute at Harbour-UCLA Medical Center, and his colleagues.

The researchers urged that the findings "be incorporated into risk-benefit discussions with women considering combined hormone therapy, especially those with a high risk of lung cancer ... such as current smokers or long-term past smokers."

Dr. Apar Kishor Ganti, from the University of Nebraska Medical Center in Omaha, wrote in an accompanying editorial that "because the optimum safe duration of hormone-replacement therapy in terms of lung cancer survival is unclear, such therapy should probably be avoided in women at a high risk of developing lung cancer, especially those with a history of smoking."

In fact, Ganti questioned whether hormone therapy should be used at all.

"These results, along with the findings showing no protection against coronary heart disease, seriously question whether hormone-replacement therapy has any role in medicine today," he wrote. "It is difficult to presume that the benefits of routine use of such therapy for menopausal symptoms outweigh the increased risks of mortality, especially in the absence of improvement in the quality of life."

The study, which appears online and in an upcoming print issue of The Lancet, was released Sept. 19 to coincide with the European Cancer Organization meeting.

More information

The U.S. National Institute on Aging has more on hormones and menopause.

SOURCE: The Lancet, news release, Sept. 19, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Menopausal Hormone Therapy Merrick NY
Hot flashes, mood swings, night sweats, sleeplessness – all are among the symptoms of female menopause. One solution is hormone therapy, in which women are supplemented with hormones including estrogen and/or progesterone.
- Head and Neck Cancer Treatment Merrick NY
- Hormone Therapy Merrick NY
- Delayed Prostate Cancer Therapy Merrick NY
- Hormone Therapy for Breast Cancer Merrick NY
- Drug Combo Proves Powerful Against Lung Cancer Merrick NY
- Hormone Therapy for Prostate Cancer Merrick NY
- Breast Cancer Treatment Merrick NY
- Hormone Therapy for Early Prostate Cancer Merrick NY